HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 90 filers reported holding HEALTH CATALYST INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $549 | +9.8% | 47,031 | 0.0% | 0.28% | +3.3% |
| Q4 2022 | $500 | -99.9% | 47,031 | -15.2% | 0.27% | -13.4% |
| Q3 2022 | $538,000 | -33.8% | 55,434 | -1.2% | 0.31% | -31.7% |
| Q2 2022 | $813,000 | -44.5% | 56,132 | +0.1% | 0.46% | -32.0% |
| Q1 2022 | $1,466,000 | -33.2% | 56,069 | 0.0% | 0.67% | -22.6% |
| Q4 2021 | $2,196,000 | -21.7% | 56,069 | 0.0% | 0.87% | -10.4% |
| Q3 2021 | $2,804,000 | -10.2% | 56,069 | -0.4% | 0.97% | -7.6% |
| Q2 2021 | $3,124,000 | +18.6% | 56,286 | 0.0% | 1.05% | +6.9% |
| Q1 2021 | $2,633,000 | +7.5% | 56,286 | 0.0% | 0.98% | +7.7% |
| Q4 2020 | $2,450,000 | +18.0% | 56,286 | -0.9% | 0.91% | -3.4% |
| Q3 2020 | $2,077,000 | +25.3% | 56,775 | -0.1% | 0.95% | +6.9% |
| Q2 2020 | $1,657,000 | +140.1% | 56,813 | +115.2% | 0.88% | +7.7% |
| Q1 2020 | $690,000 | -22.0% | 26,405 | +3.5% | 0.82% | -4.0% |
| Q4 2019 | $885,000 | – | 25,500 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |